Abound Wealth Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632 Sell
3
-13
-81% -$2.79K ﹤0.01% 907
2026
Q1
$3.54K Hold
16
﹤0.01% 802
2025
Q4
$4.06K Hold
16
﹤0.01% 723
2025
Q3
$3.96K Hold
16
﹤0.01% 694
2025
Q2
$3.84K Hold
16
﹤0.01% 638
2025
Q1
$3.63K Sell
16
-3
-16% -$660 ﹤0.01% 601
2024
Q4
$3.91K Hold
19
﹤0.01% 578
2024
Q3
$4.61K Hold
19
﹤0.01% 556
2024
Q2
$4.17K Sell
19
-18
-49% -$3.91K ﹤0.01% 534
2024
Q1
$8.32K Buy
37
+18
+95% +$4.06K ﹤0.01% 408
2023
Q4
$4.18K Buy
19
+3
+19% +$634 ﹤0.01% 551
2023
Q3
$3.51K Hold
16
﹤0.01% 540
2023
Q2
$3.6K Hold
16
﹤0.01% 557
2023
Q1
$3.06K Hold
16
﹤0.01% 519
2022
Q4
$2.96K Buy
16
+10
+167% +$1.76K ﹤0.01% 457
2022
Q3
$998 Buy
+6
New +$1.22K ﹤0.01% 609

Other funds holding STE

Abound Wealth Management's STE Position: Q2 2026 in Review

Abound Wealth Management reduced its Steris (STE) stake by 81% in Q2 2026, selling an estimated $2.79K and leaving 3 shares worth $632. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Abound Wealth Management first reported a position in STE in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.32K in Q1 2024. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Abound Wealth Management held 3 shares of Steris worth $632 as of Q2 2026.
  • Abound Wealth Management sold 13 Steris shares in Q2 2026, an estimated $2.79K.
  • Steris made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #907 holding.
  • Abound Wealth Management first reported a position in Steris in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Steris position peaked at $8.32K in Q1 2024.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.